Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

Na minha lista:

Detalhes bibliográficos
Autor Corporativo:	Council for International Organizations of Medical Sciences (CIOMS)
Formato:	Livro
Idioma:	English
Publicado em:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
Assuntos:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
Acesso em linha:	Visit NHRC Library
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados

Martindale: the complete drug reference
por: Parfitt, Kathleen
Publicado em: (1999)

WHO drug information.
Publicado em: (2000)

WHO expert committee on specifications for pharmaceutical preparations
Publicado em: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Publicado em: (1992)

WHO expert committee on specifications for pharmaceutical preparations
Publicado em: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
Publicado em: (2012)

USP DI. Approved drug products and legal requirements.
Publicado em: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
por: Andersson, Sarah
Publicado em: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
Publicado em: (1997)

Pharmacology : a patient-centered nursing process approach /
por: Kee, Joyce LeFever, et al.

Drug calculations : ratio and proportion problems for clinical practice /
por: Seltzer, Meta Brown, et al.

Effective drug regulation a multicountry study /
por: Ratanawijitrasin, Sauwakon
Publicado em: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
por: DEVS Consult Nepal (P) Ltd.
Publicado em: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
por: Acharya,Kiran
Publicado em: (2018)

Regulatory Situation of Herbal Medicines
Publicado em: (1998)

A text book of pharmacognosy.
por: Raut, Bechan, et al.
Publicado em: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
por: Adhikari, SM, et al.
Publicado em: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
Publicado em: (2012)

AHFS drug information 2000
por: Snow, Elaine, K
Publicado em: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
Publicado em: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
por: Nepal Health Research Council (NHRC), et al.
Publicado em: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
por: Yadav, Raju
Publicado em: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
Publicado em: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
por: Brody, Tom
Publicado em: (2016)

Evaluation of certain veterinary drug residues in food
Publicado em: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
por: Aryal, BK, et al.
Publicado em: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
por: Pande, Sarala
Publicado em: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
por: Adhikari, Shyam Mani
Publicado em: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
por: Adhikari, Shyam Mani, Dr.
Publicado em: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
Publicado em: (1995)

Fundamentals of Clinical Trials /
por: Friedman, Lawrence M, et al.
Publicado em: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
Publicado em: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
Publicado em: (2000)

Drug policy in the Americas
por: Smith, Peter H.
Publicado em: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Publicado em: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Publicado em: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
por: Poudel, Krishna Prasad
Publicado em: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
por: Maskay, NM, et al.
Publicado em: (2016)